[1]CurrentPatentAssignee:FOGHORNTHERAPEUTICSINC-WO2019/152440,2019,A1Locationinpatent:Page/Pagecolumn118
815620-00-9
958030-46-1
2096331-94-9
200422-18-0 | β-D-Galactopyranoside, 4-nitrophenyl, monohydrate (9CI) | AA002COD | MFCD00150725
201004-23-1 | Fmoc-Lys(For)-OH | AA002D21 | MFCD00237025
201417-01-8 | D-Glucose-13c6,1,2,3,4,5,6,6-d7 | AA002DBS | MFCD00274634
189618-32-4 | 4-(4-Bromophenoxymethyl)piperidine | AA002DQ3 | MFCD08687058
19013-30-0 | 4-Methoxyphenyl mesylate | AA002EA4 | MFCD01231360
190710-79-3 | 1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4-ethyl-4,9-dihydroxy-10-[(methylamino)methyl]-, (4S)- | AA002EOA | MFCD08063729
19112-35-7 | Ethyl (2-chlorobenzoyl)acetate | AA002EZG | MFCD03424811
19164-41-1 | 2,1,3-Benzoxadiazole, 5-methyl-, 1-oxide | AA002FAY | MFCD00068057
19219-98-8 | 2,5,6-Trimethylbenzoxazole | AA002FNA | MFCD00022849
192643-83-7 | 4-(Pyridin-4-yl)but-3-yn-1-ol | AA002G3G | MFCD18384538